Jonathan Sive

1.5k total citations
30 papers, 331 citations indexed

About

Jonathan Sive is a scholar working on Hematology, Molecular Biology and Neurology. According to data from OpenAlex, Jonathan Sive has authored 30 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 10 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Jonathan Sive's work include Multiple Myeloma Research and Treatments (18 papers), Peripheral Neuropathies and Disorders (6 papers) and Cancer Treatment and Pharmacology (5 papers). Jonathan Sive is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Peripheral Neuropathies and Disorders (6 papers) and Cancer Treatment and Pharmacology (5 papers). Jonathan Sive collaborates with scholars based in United Kingdom, United States and Switzerland. Jonathan Sive's co-authors include Anthony H. Goldstone, Berthold Göttgens, Mark R. Litzow, Adele K. Fielding, Hillard M. Lazarus, David I. Marks, Susan Richards, Andrew McMillan, Selina M. Luger and Jacob M. Rowe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jonathan Sive

20 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Sive United Kingdom 10 192 152 91 83 75 30 331
Noa Tal Israel 6 164 0.9× 202 1.3× 100 1.1× 63 0.8× 51 0.7× 11 356
Elizabeth M. Alfaro Argentina 10 149 0.8× 148 1.0× 44 0.5× 55 0.7× 70 0.9× 20 277
Frédéric Baleydier France 7 160 0.8× 182 1.2× 64 0.7× 99 1.2× 64 0.9× 26 369
Jared Becksfort United States 6 139 0.7× 164 1.1× 78 0.9× 49 0.6× 83 1.1× 12 368
Lucie Šrámková Czechia 11 308 1.6× 347 2.3× 137 1.5× 66 0.8× 114 1.5× 34 481
Manabu Sotomatsu Japan 12 256 1.3× 132 0.9× 41 0.5× 164 2.0× 74 1.0× 22 393
Huyong Zheng China 11 111 0.6× 163 1.1× 59 0.6× 144 1.7× 101 1.3× 36 347
Smita Dandekar United States 6 97 0.5× 167 1.1× 82 0.9× 111 1.3× 119 1.6× 21 323
Christine L. Phillips United States 11 114 0.6× 136 0.9× 247 2.7× 103 1.2× 33 0.4× 38 381
Maaike de Bie Netherlands 9 127 0.7× 199 1.3× 86 0.9× 56 0.7× 36 0.5× 17 321

Countries citing papers authored by Jonathan Sive

Since Specialization
Citations

This map shows the geographic impact of Jonathan Sive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Sive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Sive more than expected).

Fields of papers citing papers by Jonathan Sive

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Sive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Sive. The network helps show where Jonathan Sive may publish in the future.

Co-authorship network of co-authors of Jonathan Sive

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Sive. A scholar is included among the top collaborators of Jonathan Sive based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Sive. Jonathan Sive is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Wilson, William, Rakesh Popat, Ke Xu, et al.. (2024). Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience. SHILAP Revista de lepidopterología. 5(5). 1102–1106.
5.
Xu, Ke, Elisabeth P. Nacheva, Annabel McMillan, et al.. (2024). Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma. SHILAP Revista de lepidopterología. 5(5). 1089–1091.
6.
7.
Adam, Rosalind, Corina Sas, Daniel Powell, et al.. (2024). Understanding patterns of fatigue in health and disease: protocol for an ecological momentary assessment study using digital technologies. BMJ Open. 14(5). e081416–e081416.
8.
Yong, Kwee, Annabel McMillan, Xenofon Papanikolaou, et al.. (2023). The Impact of Continuous Lenalidomide Maintenance Treatment on People Living with Multiple Myeloma - a Single-Centre Qualitative Service Evaluation. Blood. 142(Supplement 1). 6640–6640.
9.
McMillan, Annabel, et al.. (2022). Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real‐world practice. Cytometry Part B Clinical Cytometry. 104(4). 304–310.
10.
McCourt, Orla, Jonathan Sive, Xenofon Papanikolaou, et al.. (2022). The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study. Supportive Care in Cancer. 30(9). 7469–7479. 2 indexed citations
11.
Keh, Ryan, James B Lilleker, Tim Lavin, et al.. (2022). Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS). Journal of the Peripheral Nervous System. 27(4). 302–310. 4 indexed citations
12.
Khwaja, Jahanzaib, et al.. (2022). Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome. SHILAP Revista de lepidopterología. 3(3). 1021–1024. 9 indexed citations
13.
Khwaja, Jahanzaib, Shirley D’Sa, Michael P. Lunn, & Jonathan Sive. (2022). Evidence‐based medical treatment of POEMS syndrome. British Journal of Haematology. 200(2). 128–136. 5 indexed citations
14.
Wilson, William, Christopher Parrish, Gabriel Wallis, et al.. (2021). Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma. Frontiers in Oncology. 11. 703233–703233. 12 indexed citations
15.
Keddie, Stephen, et al.. (2020). High rates of venous and arterial thrombotic events in patients with POEMS syndrome: results from the UCLH (UK) POEMS Registry. Blood Advances. 4(10). 2139–2142. 11 indexed citations
16.
17.
Sive, Jonathan & Berthold Göttgens. (2014). Transcriptional network control of normal and leukaemic haematopoiesis. Experimental Cell Research. 329(2). 255–264. 21 indexed citations
18.
Oram, S., Julie A.I. Thoms, Jonathan Sive, et al.. (2013). Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia. Leukemia. 27(6). 1348–1357. 11 indexed citations
19.
Sive, Jonathan, Kirsty Thomson, Emma Morris, Katherine N. Ward, & Karl S. Peggs. (2012). Adenoviremia Has Limited Clinical Impact in the Majority of Patients Following Alemtuzumab-Based Allogeneic Stem Cell Transplantation in Adults. Clinical Infectious Diseases. 55(10). 1362–1370. 22 indexed citations
20.
Sive, Jonathan, Kirit M. Ardeshna, Franel Le Grange, et al.. (2012). Hotel-based ambulatory care for complex cancer patients: a review of the University College London Hospital experience. Leukemia & lymphoma. 53(12). 2397–2404. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noa Tal Breakdown of academic impact, for papers by Elizabeth M. Alfaro Breakdown of academic impact, for papers by Frédéric Baleydier Breakdown of academic impact, for papers by Jared Becksfort Breakdown of academic impact, for papers by Lucie Šrámková Breakdown of academic impact, for papers by Manabu Sotomatsu Breakdown of academic impact, for papers by Huyong Zheng Breakdown of academic impact, for papers by Smita Dandekar Breakdown of academic impact, for papers by Christine L. Phillips Breakdown of academic impact, for papers by Maaike de Bie
Rankless by CCL
2026